Biostatistician & Training Lead - Hybrid Role

Harvard University; Boston (MA); Hybrid; USD 85,000 - 110,000; Full time

Benefits offered by this job

Generous paid time off including parental leave

Medical, dental, and vision health insurance

Retirement plans with university contributions

Professional development opportunities

Commuter benefits and campus perks

Job summary

Harvard University is seeking a Biostatistician/Manager of Statistical Training for the Center for Biostatistics in AIDS Research (CBAR) in Boston, Massachusetts. This role involves collaborating with medical researchers on infectious disease clinical trials and overseeing supervisees' work. Applicants need a Master's degree in Biostatistics, Statistics, or related fields, along with 5+ years of experience. The job offers a hybrid work environment and a term end date of November 30, 2027, with a good chance of extension.

Qualifications

• Master's Degree in Biostatistics, Statistics, or a closely-related field required.
• 5+ years of related experience required.
• Experience with statistical software (such as SAS, R, Stata, etc.) required.

Responsibilities

• Act as a protocol statistician, collaborating with medical researchers.
• Conduct clinical trial and observational study review.
• Design and review data collection forms.

Skills

Statistical software experience (SAS, R, Stata)

Attention to detail

Organizational skills

Written communication skills

Verbal communication skills

Education

Master's degree in Biostatistics or Statistics

Tools

SAS

R

Stata

MS Office

Job description

Harvard University is seeking a Biostatistician/Manager of Statistical Training for the Center for Biostatistics in AIDS Research (CBAR) in Boston, Massachusetts. This role involves collaborating with medical researchers on infectious disease clinical trials and overseeing supervisees' work. Applicants need a Master's degree in Biostatistics, Statistics, or related fields, along with 5+ years of experience. The job offers a hybrid work environment and a term end date of November 30, 2027, with a good chance of extension.